COMPARISON OF THROMBOEMBOLI PROPHYLACTIC EFFECT OF ASPIRIN AND LOW DOSE WARFARIN IN STANDARD RISK MULTIPLE MYELOMA PATIENTS THAT TREATED WITH REGIMENS CONTAINING THALIDOMIDE

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

DADKHAHI SEYED AMIR; ANOUSHIRVANI ALI ARASH; AGHABOZORGI REZA

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: ARAK MEDICAL UNIVERSITY JOURNAL (AMUJ) Year:2017 | Volume:20 | Issue:2 (119) Page(s): 22-32

Download Full-Text

Persian Verion

View:

743

Download:

Cites:

Information Journal Paper

Title

COMPARISON OF THROMBOEMBOLI PROPHYLACTIC EFFECT OF ASPIRIN AND LOW DOSE WARFARIN IN STANDARD RISK MULTIPLE MYELOMA PATIENTS THAT TREATED WITH REGIMENS CONTAINING THALIDOMIDE

Author(s)

DADKHAHI SEYED AMIR | ANOUSHIRVANI ALI ARASH | AGHABOZORGI REZA | Issue Writer Certificate

Keywords

ASPIRINQ1

MULTIPLE MYELOMAQ1

THROMBOEMBOLIQ1

WARFARINQ2

Abstract

Background: Most of the current regimens in the treatment of MULTIPLE MYELOMA include thalidomide. Thalidomide is a modulator of the immune system and according to several studies, its main complication is THROMBOEMBOLIsm. The aim of this study is to compare the THROMBOEMBOLI prophylactic effect of ASPIRIN and low dose WARFARIN in standard risk MULTIPLE MYELOMA patients that treated with regimens containing thalidomide.Materials and Methods: In this double- blind clinical trial study, sixty- six patients with MULTIPLE MYELOMA under treatment with thalidomide-containing regimens with standard risk for THROMBOEMBOLIsm who were admitted to Khansari hospital, entered the study according to inclusion and exclusion criteria. The incidence of THROMBOEMBOLIsm in these patients was evaluated.Results: Five patients in the WARFARIN group and 2 patients in the ASPIRIN group had THROMBOEMBOLI. Chi square analyses showed no significant difference between groups (p=0.635).Conclusion: The results showed that both drugs are effective in preventing THROMBOEMBOLIsm and can be used as a prophylactic treatment.

Cites

No record.

References

WARFARIN PHARMACOGENETICS

Cite

APA: Copy

DADKHAHI, SEYED AMIR, ANOUSHIRVANI, ALI ARASH, & AGHABOZORGI, REZA. (2017). COMPARISON OF THROMBOEMBOLI PROPHYLACTIC EFFECT OF ASPIRIN AND LOW DOSE WARFARIN IN STANDARD RISK MULTIPLE MYELOMA PATIENTS THAT TREATED WITH REGIMENS CONTAINING THALIDOMIDE. ARAK MEDICAL UNIVERSITY JOURNAL (AMUJ), 20(2 (119)), 22-32. SID. https://sid.ir/paper/69282/en

Vancouver: Copy

DADKHAHI SEYED AMIR, ANOUSHIRVANI ALI ARASH, AGHABOZORGI REZA. COMPARISON OF THROMBOEMBOLI PROPHYLACTIC EFFECT OF ASPIRIN AND LOW DOSE WARFARIN IN STANDARD RISK MULTIPLE MYELOMA PATIENTS THAT TREATED WITH REGIMENS CONTAINING THALIDOMIDE. ARAK MEDICAL UNIVERSITY JOURNAL (AMUJ)[Internet]. 2017;20(2 (119)):22-32. Available from: https://sid.ir/paper/69282/en

IEEE: Copy

SEYED AMIR DADKHAHI, ALI ARASH ANOUSHIRVANI, and REZA AGHABOZORGI, “COMPARISON OF THROMBOEMBOLI PROPHYLACTIC EFFECT OF ASPIRIN AND LOW DOSE WARFARIN IN STANDARD RISK MULTIPLE MYELOMA PATIENTS THAT TREATED WITH REGIMENS CONTAINING THALIDOMIDE,” ARAK MEDICAL UNIVERSITY JOURNAL (AMUJ), vol. 20, no. 2 (119), pp. 22–32, 2017, [Online]. Available: https://sid.ir/paper/69282/en

Related Journal Papers